Avelumab First-Line Maintenance Treatment in Advanced Bladder Cancer: Practical Implementation Steps for Infusion Nurses

Immune checkpoint inhibitors, such as programmed cell death ligand 1 inhibitors pembrolizumab, nivolumab, atezolizumab, and avelumab, are used to treat patients with advanced urothelial carcinoma (UC). Based on data from the phase 3 JAVELIN Bladder 100 trial, avelumab first-line (1L) maintenance is...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Laura S., Conway, Dawn, Lapuente, Maria, Salvador, George, Fernandez Gomez, Sheila, Carroll Bullock, Andrea, Devgan, Geeta, Burns, Kathleen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2022
Materias:
Features
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071022/
https://www.ncbi.nlm.nih.gov/pubmed/35537002
http://dx.doi.org/10.1097/NAN.0000000000000465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071022/
https://www.ncbi.nlm.nih.gov/pubmed/35537002
http://dx.doi.org/10.1097/NAN.0000000000000465

Ejemplares similares